Interestingly, no seroconversion was observed in IFNAR−/− survivors (n = 2, 0%) from a 103 FFU dose of maEBOV [32], and the authors suspected no infection, suggesting that the minimal dose for infection and seroconversion is mouse-strain specific. Here, IFNAR1 is linked to infection.